Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?
- PMID: 12944552
- PMCID: PMC1770061
- DOI: 10.1136/jcp.56.9.681
Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?
Abstract
Aims: To test the ability of Ki-67 to detect cytological lesions in a screening setting and its use as a surrogate marker of human papillomavirus (HPV) infection.
Methods: A study of liquid based cytology, HPV DNA testing by MY09/MY11 consensus polymerase chain reaction (PCR), type specific PCRs, and Ki-67 immunocytochemistry on a randomly selected series of 147 patients.
Results: Comparison of the number of Ki-67 immunoreactive cells/1000 cells in the different cytological groups showed that the HSIL group yielded a significantly higher mean count than did the other groups. The number of Ki-67 immunoreactive cells/1000 cells was significantly higher in HPV-16 positive samples than in samples containing infections with other high risk types. Receiver operating characteristic curves indicated a test accuracy (area under curve) of 0.68, 0.72, and 0.86 for atypical squamous cells of undetermined significance (ASCUS), low grade squamous intraepithelial lesions (LSIL), and high grade squamous intraepithelial lesions (HSIL), respectively. Thresholds for 95% sensitivity were 0.07, 0.08, and 0.15 Ki-67 immunopositive cells/1000 cells for ASCUS, LSIL and HSIL, respectively. The threshold for 95% specificity was 1.9 Ki-67 immunopositive cells/1000 cells.
Conclusions: Ki-67 immunocytochemistry can be applied to liquid based cytology. The accuracy and diagnostic indices of the test are good when compared with those of other techniques. As part of a panel of screening procedures, it could be used as an adjunct to liquid based cytology to identify HSIL, and as a surrogate marker of HPV-16 infection.
Figures




Similar articles
-
P16INK4a as an adjunct marker in liquid-based cervical cytology.Int J Cancer. 2004 Mar 1;108(6):871-6. doi: 10.1002/ijc.11589. Int J Cancer. 2004. PMID: 14712490
-
[Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].Mikrobiyol Bul. 2008 Apr;42(2):273-82. Mikrobiyol Bul. 2008. PMID: 18697425 Turkish.
-
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.BJOG. 2004 Aug;111(8):842-8. doi: 10.1111/j.1471-0528.2004.00210.x. BJOG. 2004. PMID: 15270934
-
Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia.Oncol Rep. 2006 Feb;15(2):387-91. Oncol Rep. 2006. PMID: 16391859
-
Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.Int J Cancer. 2006 Mar 1;118(5):1254-60. doi: 10.1002/ijc.21489. Int J Cancer. 2006. PMID: 16161049
Cited by
-
Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.J Biomed Sci. 2016 May 12;23(1):42. doi: 10.1186/s12929-016-0258-z. J Biomed Sci. 2016. PMID: 27175798 Free PMC article. Clinical Trial.
-
Cervical Cancer Screening in Resource-Constrained Countries: Current Status and Future Directions.Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1461-1467. doi: 10.22034/APJCP.2017.18.6.1461. Asian Pac J Cancer Prev. 2017. PMID: 28669152 Free PMC article. Review.
-
Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.Int J Med Sci. 2013 Sep 12;10(12):1602-7. doi: 10.7150/ijms.6526. eCollection 2013. Int J Med Sci. 2013. PMID: 24151431 Free PMC article.
-
Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.J Clin Pathol. 2004 Jul;57(7):721-7. doi: 10.1136/jcp.2003.013730. J Clin Pathol. 2004. PMID: 15220365 Free PMC article.
-
Double staining cytologic samples with quantitative Feulgen-thionin and anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cells.Anal Quant Cytopathol Histpathol. 2012 Oct;34(5):273-84. Anal Quant Cytopathol Histpathol. 2012. PMID: 23301387 Free PMC article.
References
-
- Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365–71. - PubMed
-
- Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–19. - PubMed
-
- Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995;87:796–802. - PubMed
-
- Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials